---
figid: PMC11032202__fcae108f3
figtitle: Oncogenes versus tumour suppressor genes in glioblastoma
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11032202
filename: fcae108f3.jpg
figlink: /pmc/articles/PMC11032202/figure/F3
number: F3
caption: Oncogenes versus tumour suppressor genes in glioblastoma. EGFR is frequently
  mutated in glioblastoma and constitutively activates several signalling pathways,
  inhibits apoptotic cell death and increases growth and invasiveness of glioblastoma
  cells. PDGF and PDGFR are overexpressed in glioblastomas, particularly, PDGFRA.
  The overexpression of PDGFRA is associated with more aggressive phenotypes and poorer
  survival outcomes. The NF1 gene encodes neurofibromin, which inhibits the RAS/MAPK
  signalling pathway. Inactivation of two NF1 alleles is required for glioma formation.
  Vascular endothelial growth factor receptor (VEGFR), KRAS (Kirsten rat sarcoma),
  RAS (rat sarcoma), RAF (rapidly accelerated fibrosarcoma), MEK (mitogen-activated
  protein kinase), ERK (extracellular signal-regulated kinase), PI3K (phosphoinositide
  3-kinase), AKT (protein kinase B), PTEN (phosphatase and tensin homolog), BCL-XL
  (B-cell lymphoma-extra large), RB1 (retinoblastoma 1), MYC (myelocytomatosis oncogene),
  GAP (GTPase-activating protein), GDP (guanosine diphosphate), GTP (guanosine triphosphate)
  and GEF (guanine nucleotide exchange factor)
papertitle: Molecular diversity in isocitrate dehydrogenase-wild-type glioblastoma
reftext: Jawad Fares, et al. Brain Commun. 2024;6(2).
year: '2024'
doi: 10.1093/braincomms/fcae108
journal_title: Brain Communications
journal_nlm_ta: Brain Commun
publisher_name: Oxford University Press
keywords: glioblastoma | IDH-wild-type | heterogeneity | neuroimaging | machine learning
automl_pathway: 0.9535623
figid_alias: PMC11032202__F3
figtype: Figure
redirect_from: /figures/PMC11032202__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11032202__fcae108f3.html
  '@type': Dataset
  description: Oncogenes versus tumour suppressor genes in glioblastoma. EGFR is frequently
    mutated in glioblastoma and constitutively activates several signalling pathways,
    inhibits apoptotic cell death and increases growth and invasiveness of glioblastoma
    cells. PDGF and PDGFR are overexpressed in glioblastomas, particularly, PDGFRA.
    The overexpression of PDGFRA is associated with more aggressive phenotypes and
    poorer survival outcomes. The NF1 gene encodes neurofibromin, which inhibits the
    RAS/MAPK signalling pathway. Inactivation of two NF1 alleles is required for glioma
    formation. Vascular endothelial growth factor receptor (VEGFR), KRAS (Kirsten
    rat sarcoma), RAS (rat sarcoma), RAF (rapidly accelerated fibrosarcoma), MEK (mitogen-activated
    protein kinase), ERK (extracellular signal-regulated kinase), PI3K (phosphoinositide
    3-kinase), AKT (protein kinase B), PTEN (phosphatase and tensin homolog), BCL-XL
    (B-cell lymphoma-extra large), RB1 (retinoblastoma 1), MYC (myelocytomatosis oncogene),
    GAP (GTPase-activating protein), GDP (guanosine diphosphate), GTP (guanosine triphosphate)
    and GEF (guanine nucleotide exchange factor)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - PDGFRB
  - PDGFRA
  - KDR
  - FLT1
  - FLT4
  - PIK3CA
  - PTEN
  - CDKN2A
  - TP53
  - RB1
  - RBM45
  - MYC
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - MTG1
  - RASA1
  - RGS6
  - ARHGEF2
  - SLC2A4RG
  - NF1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - GDP
  - RAS
  - GTP
  - GAP
  - MEK
---
